Testing Overall and Subpopulation Treatment Effects with Measurement Errors

Area of Science:

• Biostatistics
• Translational Medicine
• Biomarker Discovery

Background:

• Biomarkers are crucial for predicting treatment efficacy, especially when a threshold value indicates effectiveness.
• Measurement errors in biomarker expression can obscure predictive capabilities, leading to misclassification and suboptimal treatment choices.

Purpose of the Study:

• To develop a novel statistical testing procedure for evaluating treatment effects in the presence of biomarker measurement errors.
• To enhance the accuracy of patient stratification and therapeutic decision-making by accounting for biomarker variability.

Main Methods:

• A new testing procedure within a multiple testing framework is proposed.
• The method directly incorporates measurement error considerations, avoiding computationally intensive resampling techniques.
• Statistical simulations were performed to assess the method's performance.

Main Results:

• The proposed method effectively identifies predictive biomarkers despite measurement errors.
• It provides a computationally feasible approach for analyzing treatment effects in biomarker-driven studies.
• Simulation results demonstrate the method's robustness and accuracy.

Conclusions:

• The developed procedure offers a reliable way to assess treatment effects and identify predictive biomarkers when measurement errors are present.
• This method can lead to more accurate patient classification and improved therapeutic strategies.
• It provides a practical alternative to resampling methods in biomarker research.